-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Regeneron Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2023.
- Regeneron Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was $1.51B, a 10.6% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $4.59B, a 8.39% decline from 2022.
- Regeneron Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $5.01B, a 29.2% decline from 2021.
- Regeneron Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $7.08B, a 170% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)